Antifungal antibiotic hamycin increases susceptibility of Candida albicans to phagocytosis by murine macrophages

FEMS Immunology and Medical Microbiology

Volumn 20, Issue 2, 1998, Pages 153-157

  Dhuley, Jayant N ^a  

^a Hindustan Antibiotics Ltd   (India)

Author keywords

Candida albicans; Hamycin; Macrophage; Phagocytosis

Indexed keywords

HAMYCIN;

ANIMAL CELL; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANIMALS; ANTIBIOTICS, ANTIFUNGAL; CANDIDA ALBICANS; CELLS, CULTURED; FORMALDEHYDE; KINETICS; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C3H; PHAGOCYTOSIS; POLYENES; SURFACE PROPERTIES;

EID: 0031971761     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(98)00005-4     Document Type: Article

References (19)

1. Thirumalachar, M.J., Menon, S.K. and Bhatt, V.V. (1961) Hamycin, a new antifungal antibiotic. I. Discovery and biological studies. Hindustan Antibiot. Bull. 3, 136-138.
2. Thirumalachar, M.J. and Narsimhan, M.J. (1987) Hamycin: twenty years and the future. In: Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents (Fromtling, R.A., Ed.) pp. 619-632. J.R. Prous Science Publishers, Barcelona, Spain.
3. Gokhale, B.B., Padhye, A.A. and Joglekar, M.V. (1963) Hamycin in the treatment of cutaneous candidiasis. Indian Practit. 16, 267-271.
4. Grant, K.B. and Ichaporia, R.N. (1964) Treatment of internal mycotic infections with hamycin. Hindustan Antibiot. Bull. 7, 63-68.
5. Utz, J.P., Witorsch, P., Williams, T.W., Emmons, C.W., Jean Shadomy, H. and Piggott, W.R. (1967) Hamycin: chemotherapeutic studies in systemic mycoses in man. Am. Rev. Respir. Dis. 95, 506-509.
6. Ichaporia, R.N. (1969) Experience with Hamycin in mycotic infactions. Hindustan Antibiot. Bull. 12, 7-8.
7. Radha, T.G. and Vishwanathan, R. (1978) Allergic broncho-pulmonary aspergillosi. Respiration 36, 104-111.
8. Evron, R. (1980) In vitro phagocytosis of Candida albicans by peritoneal mouse macrophages. Infect. Immunol. 28, 963-971.
9. Sarthou, P., Primi, D. and Cazenave, P.A. (1986) B cell triggering properties of a non-toxic derivatives of amphotericin B. J. Immunol. 137, 2156-2161.
10. Gelfand, J.A., Kimball, K., Burke, J.F. and Dinarello, C.A. (1988) Amphotericin B treatment of human mononuclear cells in vitro results in secretion of tumor necrosis factor and interleukin. Clin. Res. 36, 456-458.
11. Van der Auwera, P. (1988) The immunomodulating effects of antibiotics. Curr. Opin. Infect. Dis. 1, 363-374.
12. Pandey, R.C. and Rinehart, K.L. (1977) An improved method for the preparation of methylesters of polyene antibiotics. J. Antibiot. 30, 158-162.
13. Tansho, S., Abe, S. and Yamaguchi, H. (1994) Inhibition of Candida albicans growth by murine peritoneal neutrophils and its augmentation of the inhibitory activity by bacterial lipopolysaccharide and cytokines. Microbiol. Immunol. 38, 379-386.
14. Klotz, S.A., Drutz, D.J. and Zajic, J.E. (1985) Factors governing adherence of Candida species to plastic surfaces. Infect. Immunol. 50, 97-101.
15. Hazen, K.C. (1989) Participation of yeast cell surface hydrophobicity in adherence of Candida albicans to human epithelial cells. Infect. Immunol. 57, 1894-1900.
16. Marodi, L., Korchak, H.M. and Johnston, R.B. (1991) Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages. J. Immunol. 146, 2783-2789.
17. McCourtie, J. and Douglas, L.J. (1984) Relationship between cell surface composition, adherence and virulence of Candida albicans. Infect. Immunol. 45, 6-12.
18. Antley, P.P. and Hazen, K.C. (1988) Role of yeast cell growth temperature on Candida albicans virulence in mice. Infect. Immunol. 56, 2884-2890.
19. Chia, J.K.S. and Pollack, M. (1989) Amphotericin B induces tumor necrosis factor production by murine macrophages. J. Infect. Dis. 158, 113-116.